Acta Neurochirurgica

, Volume 155, Issue 12, pp 2255–2261 | Cite as

Postsurgical screening for psychosocial disorders in neurooncological patients

  • M. Renovanz
  • A. Gutenberg
  • M. Haug
  • E. Strittmatter
  • J. Mazur
  • M. Nadji-Ohl
  • A. Giese
  • N. Hopf
Clinical Article - Brain Tumors



The diagnosis of a brain tumor can cause severe psychosocial distress, which can have a variety of negative consequences on patients' physical and mental well-being. The detection of psychosocial distress in daily clinical routine is difficult and subsequent referral to mental health professionals is rare. The aim of this study was to determine the incidence of psychological disorders of patients early postoperatively and to investigate both the Hornheide Screening Instrument (HSI) and Distress Thermometer (DT) as screening tools in neurooncological practice.


One hundred and thirty-four patients with brain tumors of different histology were postoperatively evaluated by the Distress Thermometer and Hornheide Screening Instrument. Additionally, correlation to gender, age, localization of the tumor, Karnofsky performance score and tumor entity were analyzed.


After initial surgery 36 patients (26.9 %) showed pathologic results in the HSI and 50 patients (36.7 %) were severely distressed (DT Score ≥ 6). Women had the highest rate of psychological disorders, followed by patients suffering from gliomas and meningiomas. Further highlighting the results of both tests, over 80 % of those patients who scored pathologically in both tests were in need of professional psychiatric help due to depression.


Both the DT and HSI are suitable instruments for identifying patients in psychological distress after brain tumor surgery in neurooncological routine. Our results confirm that nearly one third of patients are unable to overcome the difficulties facing the diagnosis of a brain tumor in this early situation and should be supported by mental health professionals.


Brain tumor Psychosocial disorders Postoperative distress Screening instruments 



The authors would like to thank the Friedhelm-Frees-Stiftung in Mainz for kindly supporting the bicentric psycho-oncological screening projects of the two institutions – Mainz and Stuttgart.

Conflict of Interest



  1. 1.
    Angenendt G, Schütze-Kreilkamp U, Tschuschke von Haug V (2010) Praxis der Psychoonkologie: Psychoedukation, Beratung und Therapie. Stuttgart,pp 13–18Google Scholar
  2. 2.
    Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA, Quinn HE, Guill AB, Herdon JE 2nd, Raynor RH (2008) Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 10(2):171–181PubMedCrossRefGoogle Scholar
  3. 3.
    Acquaye AA, Vera-Bolanos E, Armstrong TS, Gilbert MR, Lin L (2013) Mood disturbance in glioma patients. J Neurooncol 113(3):505–512PubMedCrossRefGoogle Scholar
  4. 4.
    Bullinger M, Siegrist J (2000). Entwicklung und klinischer Einsatz von Screening-Instrumenten zur Identifikation betreuungsbedürftiger Tumorpatienten. Lebensqualitätsforschung aus medizinpsychologischer und - soziologischer Perspektive. Jahrbuch der Medizinischen Psychologie, pp. 59–75Google Scholar
  5. 5.
    Fischbeck S, Kohlhof H, Hardt J, Hertel F, Wiewrodt D (2011) Burden and need for psychosocial intervention of glioblastoma patients. Psychother Psychosom Med Psychol 61(12):518–524PubMedCrossRefGoogle Scholar
  6. 6.
    Flanigan JC, Jilaveanu LB, Chiang VL, Kluger HM (2013) Advances in therapy for melanoma brain metastases. Clin Dermatol 31(3):264–281PubMedCrossRefGoogle Scholar
  7. 7.
    Goebel S, Stark AM, Kaup L, Von Harscher M, Mehdorn HM (2011) Distress in patients with newly diagnosed brain tumours. Psychooncology 20(6):623–630PubMedCrossRefGoogle Scholar
  8. 8.
    Goebel S, Mehdorn HM (2011) Measurement of psychological distress in patients with intracranial tumours: the NCCN distress thermometer. J Neurooncol 104(1):357–364PubMedCrossRefGoogle Scholar
  9. 9.
    Goebel S, Kaup L, Wiesner CD, Mehdorn HM (2013) Affective state and cognitive functioning in patients with intracranial tumors: validity of the neuropsychological baseline assessment. Psychooncology 22(6):1319–1327PubMedCrossRefGoogle Scholar
  10. 10.
    Herschbach P, Heußner P, Sellschopp A (2006). Screening-Instrumente zur Ermittlung der Betreuungsbedürftigkeit von Tumorpatienten. Psychoonkologie. Perspektiven heute, pp. 122–142Google Scholar
  11. 11.
    Keir ST, Calhoun-Eagan RD, Swartz JJ, Saleh OA, Friedman HS (2008) Screening for distress in patients with brain cancer using the NCCN’s rapid screening measure. Psychooncology 17(6):621–625PubMedCrossRefGoogle Scholar
  12. 12.
    Keir ST, Farland MM, Lipp ES, Friedman HS (2008) Distress persists in long-term brain tumor survivors with glioblastoma multiforme. J Cancer Surviv 2(4):269–274PubMedCrossRefGoogle Scholar
  13. 13.
    Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, Morrow GR, Chinnery LW, Chesney MJ, Gralla RJ, Grunberg SM (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24:2932–2947PubMedCrossRefGoogle Scholar
  14. 14.
    Kvale EA, Murthy R, Taylor R, Lee JY, Nabors LB (2009) Distress and quality of life in primary high-grade brain tumor patients. Support Care Cancer 17(7):793–799PubMedCrossRefGoogle Scholar
  15. 15.
    Langley RR, Fidler IJ (2013) The biology of brain metastasis. Clin Chem 59(1):180–189PubMedCrossRefGoogle Scholar
  16. 16.
    Linden W, Vodermaier A, Mackenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2–3):343–351PubMedCrossRefGoogle Scholar
  17. 17.
    Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER (2004) Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurg 54(2):358–366CrossRefGoogle Scholar
  18. 18.
    Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2009) Somatization symptoms are related to right-hemispheric primary brain tumor: a population-based prospective study of tumor patients in northern Finland. Psychosomatics 50(4):331–335PubMedCrossRefGoogle Scholar
  19. 19.
    Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006) Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 21(3):194–199PubMedCrossRefGoogle Scholar
  20. 20.
    Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2011) Depression in relation to anxiety, obsessionality and phobia among neurosurgical patients with a primary brain tumor: a 1-year follow-up study. Clin Neurol Neurosurg 113(8):649–653PubMedCrossRefGoogle Scholar
  21. 21.
    Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P (2006) Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci 256(8):516–521PubMedCrossRefGoogle Scholar
  22. 22.
    Mehnert A, Lehmann C, Schulte T, Koch U (2007) Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation. Onkologie 30(11):551–556PubMedCrossRefGoogle Scholar
  23. 23.
    Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22:111–122PubMedCrossRefGoogle Scholar
  24. 24.
    Pringle AM, Taylor R, Whittle IR (1999) Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13(1):46–51PubMedCrossRefGoogle Scholar
  25. 25.
    R Core Team (2013) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL:
  26. 26.
    Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103(1):61–76PubMedCrossRefGoogle Scholar
  27. 27.
    Rumpold G, Augustin M, Zschocke I, Strittmatter G, Söllner W (2001) The validity of the Hornheide questionnaire for psychosocial support in skin tumor patients: a survey in an Austrian and German outpatient population with melanoma. Psychother Psychosom Med Psychol 51(1):25–33PubMedCrossRefGoogle Scholar
  28. 28.
    Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS (2008) Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer 113(7):1641–1648PubMedCrossRefGoogle Scholar
  29. 29.
    Strittmatter G, Tilkorn M, Mawick R (2002) How to identify patients in need of psychological intervention. Recent Results Cancer Res 160:353–361PubMedCrossRefGoogle Scholar
  30. 30.
    Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996PubMedCrossRefGoogle Scholar
  31. 31.
    Taillibert S, Laigle-Donadey F, Sanson M (2004) Palliative care in patients with primary brain tumors. Curr Opin Oncol 16(6):587–592PubMedCrossRefGoogle Scholar
  32. 32.
    Tilkorn M, Mawick R, Sommerfeld S, Strittmatter G (1990) Quality of life of patients with malignant facial and skin tumors-development of a questionnaire and initial findings of a study. Die Rehabil (Stuttg) 29(2):134–139Google Scholar
  33. 33.
    Warrington TP, Bostwick JM (2006) Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 81:1361–1367PubMedCrossRefGoogle Scholar
  34. 34.
    Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167(4):913–920PubMedCrossRefGoogle Scholar
  35. 35.
    Wick W, Hartmann C, Engel C, Stoffels M, Felsberg J, Stockhammer F, Sabel MC, Koeppen S, Ketter R, Meyermann R, Rapp M, Meisner C, Kortmann RD, Pietsch T, Wiestler OD, Ernemann U, Bamberg M, Reifenberger G, von Deimling A, Weller M (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27(35):5874–5880PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • M. Renovanz
    • 1
  • A. Gutenberg
    • 1
  • M. Haug
    • 2
  • E. Strittmatter
    • 3
  • J. Mazur
    • 4
  • M. Nadji-Ohl
    • 2
  • A. Giese
    • 1
  • N. Hopf
    • 2
  1. 1.Department of NeurosurgeryUniversity Medical Center, Johannes-Gutenberg-University MayenceMayenceGermany
  2. 2.Department of NeurosurgeryKlinikum Stuttgart, Katharinen hospitalStuttgartGermany
  3. 3.Fachklinik HornheideMünsterGermany
  4. 4.Institute of Medical Biostatistics, Epidemiology and InformaticsMayenceGermany

Personalised recommendations